Exploring the Role of Obesity in Dilated Cardiomyopathy Based on Bio-informatics Analysis

Xuehua Wang1,2,3, Wei Liu1,2,3,4, Huili Li1,2,3

  • 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Obesity increases dilated cardiomyopathy (DCM) risk by disrupting the immune environment, promoting oxidative stress, and causing fibrosis. Key genes like KLHL29 and HTRA1 are implicated in this process.

Area of Science:

  • Cardiovascular Biology
  • Obesity Research
  • Genomics

Background:

  • Obesity is a significant risk factor for cardiovascular disease (CVD), including an elevated risk of dilated cardiomyopathy (DCM).
  • Understanding the biological mechanisms linking obesity to DCM is crucial for public health.
  • Recent studies highlight the association between obesity and increased DCM incidence.

Purpose of the Study:

  • To investigate the underlying biological role of obesity in increasing the risk of dilated cardiomyopathy (DCM).
  • To identify common genes and pathways affected by both obesity and DCM.
  • To explore the relationship between key genes and immune cell composition in obesity-related DCM.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets (GSE120895, GSE19303, GSE2508) for differential gene expression analysis.
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
  • Employed LASSO algorithm for key gene identification and ROC curves for validation, alongside CIBERSORT for immune cell analysis and Spearman's correlation for gene-immune cell interactions.

Main Results:

  • Common genes between obesity and DCM were enriched in pathways including transforming growth factor-beta (TGF-β), fibrillar collagen, NADPH oxidase activity, and hormone signaling.
  • Obesity and DCM exhibited disordered immune environments, with obesity showing more significant alterations.
  • Identified key genes NOX4, CCDC80, COL1A2, HTRA1, and KLHL29, with KLHL29 correlating with T cells/M2 macrophages and HTRA1 with plasma cells.

Conclusions:

  • Obesity disrupts the immune micro-environment, promotes oxidative stress, and increases myocardial fibrosis, contributing to ventricular remodeling and DCM risk.
  • Bio-informatics analysis suggests key genes KLHL29 and HTRA1 play critical roles in obesity-related DCM.
  • These findings provide insights into the molecular mechanisms underlying obesity-induced DCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
36
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
23